Results for tag: "Dimethyl Fumarate"

Dimethyl Fumarate (DMF) is a drug used to treat immune disorders, such as multiple sclerosis (MS). It is an oral medication that works by reducing inflammation and slowing down the progression of MS. DMF is believed to work by activating the Nrf2 pathway, which helps protect cells from damage caused by oxidative stress. It is also thought to reduce the number of white blood cells that attack the central nervous system. DMF is generally well-tolerated and has few side effects. DMF is a relatively new drug, and its use in the treatment of immune disorders is still being studied. It is approved for use in the United States, Europe, and other countries. In the US, it is marketed under the brand name Tecfidera. The DMF market is growing rapidly, as more people are being diagnosed with immune disorders and the need for effective treatments increases. There are several companies that are involved in the production and distribution of DMF, including Biogen, Merck, and Novartis. These companies are working to develop new formulations of DMF and to expand its use in the treatment of immune disorders. Show Less Read more